Advertisement

Reactions Weekly

, Volume 1091, Issue 1, pp 2–2 | Cite as

US FDA releases hold on Tysabri trial

Media release
  • 5 Downloads

Keywords

Rheumatoid Arthritis Multiple Sclerosis Progressive Multifocal Leukoencephalopathy Natalizumab Safety Evaluation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International limited or Adis Data Information BV 2006

Personalised recommendations